Benzinga | Sep 14, 2020 06:25AM EDT

HC Wainwright & Co. Downgrades Immunomedics to Neutral, Raises Price Target to $88

HC Wainwright & Co. downgrades Immunomedics (NASDAQ:IMMU) from Buy to Neutral and raises the price target from $56 to $88.